(Q41143385)

English

Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning--a brief review of the evidence

scientific article published on July 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

1 reference

Europe PubMed Central

Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning--a brief review of the evidence (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

author name string

Parratt JR

1

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Vegh A

2

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Papp JG

3

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

publication date

1 July 1995

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Canadian Journal of Physiology and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

73

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

837-842

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor

1 reference

https://api.crossref.org/works/10.1139%2FY95-114

21 January 2018

Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery

1 reference

https://api.crossref.org/works/10.1139%2FY95-114

21 January 2018

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1139%2FY95-114

21 January 2018

Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs

1 reference

https://api.crossref.org/works/10.1139%2FY95-114

21 January 2018

Endogenous myocardial protective (antiarrhythmic) substances

1 reference

https://api.crossref.org/works/10.1139%2FY95-114

21 January 2018

Cardioprotection by angiotensin converting enzyme inhibitors--the experimental evidence

1 reference

https://api.crossref.org/works/10.1139%2FY95-114

21 January 2018

Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs

1 reference

https://api.crossref.org/works/10.1139%2FY95-114

21 January 2018

The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic effect of ischaemic preconditioning

1 reference

https://api.crossref.org/works/10.1139%2FY95-114

21 January 2018

Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs

1 reference

https://api.crossref.org/works/10.1139%2FY95-114

21 January 2018

Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors

1 reference

https://api.crossref.org/works/10.1139%2FY95-114

21 January 2018

Enzymes in normally perfused and ischaemic dog hearts which release a substance with kinin like activity

1 reference

https://api.crossref.org/works/10.1139%2FY95-114

21 January 2018

Identifiers

10.1139/Y95-114

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41143385&oldid=1915962002"